Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo

British Journal of Dermatology

Volumn 157, Issue 6, 2007, Pages 1161-1167

  Durupt, F ^a,b   Mayor, L ^a,b   Bes, M ^a,b   Reverdy, M E ^a,b   Vandenesch, F ^a,b   Thomas, L ^b   Etienne, J ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Exfoliative toxins; Furunculosis; Impetigo; Methicillin resistance; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

BACTERIAL TOXIN; EXFOLIATIN; PANTON VALENTINE LEUKOCIDIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CHRONICITY; CLINICAL FEATURE; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; FURUNCULOSIS; GENE EXPRESSION; HUMAN; IMPETIGO; IMPETIGO BULLOSA; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CULTURE; STAPHYLOCOCCUS AUREUS; TIME SERIES ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; EXFOLIATINS; EXOTOXINS; FEMALE; FURUNCULOSIS; HUMANS; IMPETIGO; LEUKOCIDINS; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; PROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS;

EID: 36148933029     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08197.x     Document Type: Article

References (46)

1. Gravet A, Couppié P, Meunier O et al. Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol 2001 39 : 4349 56.
2. Dufour P, Gillet Y, Bes M et al. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002 35 : 819 24.
3. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003 9 : 978 84.
4. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005 5 : 275 86.
5. Liassine N, Auckenthaler R, Descombes MC et al. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004 42 : 825 8.
6. Yamaguchi T, Yokota Y, Terajima J et al. Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district in Japan. J Infect Dis 2002 185 : 1511 16.
7. Tulloch LG. Nasal carriage in staphylococcal skin infections. Br Med J 1954 ii : 912 13.
8. Wertheim HF, Melles DC, Vos MC et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005 5 : 751 62.
9. Raz R, Miron D, Colodner R et al. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996 156 : 1109 12.
10. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology. New York : Greene Publishing Associates and Wiley Interscience, 1987.
11. Lina G, Boutite F, Tristan A et al. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Appl Environ Microbiol 2003 69 : 18 23.
12. Jarraud S, Mougel C, Thioulouse J et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002 70 : 631 41.
13. Murakami K, Minamide W, Wada K et al. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J Clin Microbiol 1991 29 : 2240 4.
14. De Buyser ML, Morvan A, Grimont F et al. Characterization of Staphylococcus species by ribosomal RNA gene restriction patterns. J Gen Microbiol 1989 135 : 989 99.
15. Blanc DS, Struelens MJ, Deplano A et al. Epidemiological validation of pulsed-field gel electrophoresis patterns for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2001 39 : 3442 5.
16. Goering RV, Winters MA. Rapid method for epidemiological evaluation of Gram-positive cocci by field inversion gel electrophoresis. J Clin Microbiol 1992 30 : 577 80.
17. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995 33 : 2233 9.
18. Ferry T, Bes M, Dauwalder O et al. Toxin gene content of the Lyon methicillin-resistant Staphylococcus aureus clone compared with that of other pandemic clones. J Clin Microbiol 2006 44 : 2642 4.
19. Lescure FX, Locher G, Eveillard M et al. Community-acquired infection with healthcare-associated methicillin-resistant Staphylococcus aureus: the role of home nursing care. Infect Control Hosp Epidemiol 2006 27 : 1213 18.
20. Cribier B, Prevost G, Couppié P et al. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992 185 : 175 80.
21. Lina G, Piemont Y, Godail-Gamot F et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999 29 : 1128 32.
22. Couppié P, Cribier B, Prevost G. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994 130 : 1208 9.
23. Yamasaki O, Kaneko J, Morizane S et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 2005 40 : 381 5.
24. Baba Moussa L, Sanni A, Dagnra AY et al. Approche épidé miologique de l'antibiorésistance et de la production de leucotoxines par les souches de Staphylococcus aureus isolées en Afrique de l'Ouest. Med Mal Infect 1999 29 : 689 96.
25. Issartel B, Tristan A, Lechevallier S et al. Frequent carriage of Panton-Valentine leucocidin genes by Staphylococcus aureus isolates from surgically drained abscesses. J Clin Microbiol 2005 43 : 3203 7.
26. Pan ES, Diep BA, Carleton HA et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003 37 : 1384 8.
27. Kazakova SV, Hageman JC, Matava M et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005 352 : 468 75.
28. Stemper ME, Shukla SK, Reed KD. Emergence and spread of community-associated methicillin-resistant Staphylococcus aureus in rural Wisconsin, 1989 to 1999. J Clin Microbiol 2004 42 : 5673 80.
29. Baggett HC, Hennessy TW, Leman R et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 2003 24 : 397 402.
30. Labandeira-Rey M, Couzon F, Boisset S et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007 315 : 1130 3.
31. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996 334 : 240 5.
32. Demidovich CW, Wittler RR, Ruff ME et al. Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies. Am J Dis Child 1990 144 : 1313 15.
33. Dagan R, Bar-David Y. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 1992 36 : 287 90.
34. Koning S, van Suijlekom-Smit LW, Nouwen JL et al. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ 2002 324 : 203 6.
35. Amagai M, Matsuyoshi N, Wang ZH et al. Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000 6 : 1275 7.
36. Wertheim HF, Vos MC, Ott A et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004 364 : 703 5.
37. Luzar MA, Coles GA, Faller B et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990 322 : 505 9.
38. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997 10 : 505 20.
39. Hurdle JG, O'Neill AJ, Mody L et al. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005 56 : 1166 8.
40. Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998 41 : 11 18.
41. Howden BP, Grayson ML. Dumb and dumber - the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006 42 : 394 400.
42. Ellis MW, Hospenthal DR, Dooley DP et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004 39 : 971 9.
43. Del Giudice P, Blanc V, Durupt F et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006 154 : 118 24.
44. Robert J, Etienne J, Bertrand X. Methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a retrospective case series from 12 French hospital laboratories, 2000-2003. Clin Microbiol Infect 2005 11 : 585 7.
45. Kaplan SL, Hulten KG, Gonzalez BE et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005 40 : 1785 91.
46. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006 355 : 666 74.